therapeutic 4,477 words KG: sulforaphane
Contents

Sulforaphane and Nrf2 Activation for Neuroprotection

💊 Therapeutic Info
Namesulforaphane
Key Genes/ProteinsAMPK, LC3, NRF2
Related Diseasescerebral ischemia/reperfusion injury
Related Pathwayslipophagy

No AI portrait yet

Knowledge Graph

Agent Input

💡 Improve this page

🌐 Cross-references

Wikipedia

Related Hypotheses (20)

Context-Dependent CRISPR Activation in Specific Neuronal Sub
Score: 0.68
Purinergic Signaling Polarization Control
Score: 0.71
Matrix Stiffness Normalization via Targeted Lysyl Oxidase In
Score: 0.71
Mechanosensitive Ion Channel Reprogramming
Score: 0.70
Lipid Droplet Dynamics as Phenotype Switches
Score: 0.67
Microbial Inflammasome Priming Prevention
Score: 0.65
Palmitoylation-Targeted BACE1 Trafficking Disruptors
Score: 0.69
APOE-Dependent Autophagy Restoration
Score: 0.89
Epigenetic Memory Erasure via TET2 Activation
Score: 0.74
PARP1 Inhibition Therapy
Score: 0.74
Metabolic Switch Targeting for A1→A2 Repolarization
Score: 0.73
Circadian-Synchronized LRP1 Pathway Activation
Score: 0.71
Nutrient-Sensing Epigenetic Circuit Reactivation
Score: 0.70
Lysosomal Calcium Channel Modulation Therapy
Score: 0.70
Extracellular Matrix Stiffness Modulation
Score: 0.69
Aquaporin-4 Polarization Enhancement via TREK-1 Channel Modu
Score: 0.67
The Mitochondrial-Lysosomal Metabolic Coupling Dysfunction
Score: 0.65
TFEB-PGC1α Mitochondrial-Lysosomal Decoupling
Score: 0.62
HSP90-Tau Disaggregation Complex Enhancement
Score: 0.57
Microbiome-Derived Tryptophan Metabolite Neuroprotection
Score: 0.43

Related Analyses (16)

Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · completed
Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · completed
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · completed
Astrocyte Reactivity Subtypes in Neurodegeneration
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · completed

Related Experiments (7)

Cytochrome Therapeutics
clinical · proposed · Score: 0.40
Acteoside treatment in LPS-induced SALI mouse model
validation · proposed · Score: 0.90
Acteoside effects on RAW264.7 macrophage cells
exploratory · proposed · Score: 0.85
Nrf2 inhibitor ML385 mechanism validation experiment
exploratory · proposed · Score: 0.85
RBG treatment in ApoE-/- atherosclerosis mouse model
validation · proposed · Score: 0.90

See Also (15)

Neuroinflammation PET Imaging in CBS/PSP
diagnostic · KG edge: inhibits
TFEB (Redirect)
redirect · KG edge: activates
MAP1LC3A Gene
gene · KG edge: contributes_to
Lipophagy Pathway in Neurodegeneration
mechanism · KG edge: activates
NRF2 Activator Therapy
idea · KG edge: activates

Knowledge Graph (6 edges)

sulforaphane activates lipophagy
sulforaphane contributes_to LC3
sulforaphane activates NRF2
sulforaphane treats cerebral ischemia/reperfusion injury
sulforaphane activates AMPK
27143001 activates sulforaphane

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.